Skip to main content
Year archive

PCI Biotech Holding — 2016 filings

All 67 regulatory filings released by PCI Biotech Holding (PCIB) in 2016, sourced directly from the official regulator.

67 Filings
2016 Period
2016 filings (67)
Filing Released Lang
PCI Biotech: Mandatory notification regarding exercise and trade of subscription rights and trade of shares
Share Issue/Capital Change
2016-12-21 English
PCI Biotech: Mandatory notification regarding exercise and trade of subscription rights and trade of shares
Declaration of Voting Results & Voting Rights Announcements
2016-12-21 English
PCI Biotech: Mandatory notification of trade
Director's Dealing
2016-12-14 English
PCI Biotech: Successful Investigational New Drug (IND) application
Regulatory Filings
2016-12-14 English
Oslo Børs - The subscription rights in PCI Biotech Holding ASA the quoted company will be listed 14.12.2016
Share Issue/Capital Change
2016-12-14 English
PCI Biotech: Commencement of subscription period
Share Issue/Capital Change
2016-12-14 English
PCI Biotech: Commencement of subscription period
Capital/Financing Update
2016-12-14 English
PCI Biotech: Commencement of subscription period
Share Issue/Capital Change
2016-12-14 English
PCI Biotech: Update on the existing pre-clinical research collaboration agreement with a top-10 large pharma company
M&A Activity
2016-12-13 English
PCI Biotech: Prospectus approved
Capital/Financing Update
2016-12-13 English
Oslo Børs - The subscription rights in PCI Biotech Holding ASA the quoted company will be listed 14.12.2016
Share Issue/Capital Change
2016-12-13 English
Ex fortrinnsretter i dag
Share Issue/Capital Change
2016-12-09 Norwegian
Ex rights issue today
Share Issue/Capital Change
2016-12-09 English
PCIB - Disclosure of large shareholding
Major Shareholding Notification
2016-12-08 English
PCI Biotech and eTheRNA immunotherapies initiate research collaboration
Regulatory Filings
2016-12-08 English
PCI Biotech and eTheRNA immunotherapies initiate research collaboration
Regulatory Filings
2016-12-08 English
PCI Biotech: Rights issue approved by the extraordinary general meeting
AGM Information
2016-12-08 Norwegian
PCI Biotech: Rights issue approved by the extraordinary general meeting
AGM Information
2016-12-08 English
PCI Biotech: Disclosure of voting rights
Declaration of Voting Results & Voting Rights Announcements
2016-12-07 English
Financial calendar
Report Publication Announcement
2016-11-23 English
PCI Biotech: Third quarter 2016 results
Interim / Quarterly Report Q3 2016
2016-11-22 English
PCI Biotech: Third quarter 2016 results
Earnings Release Q3 2016
2016-11-22 English
OSLO BØRS - MATCHING HALT ENDS
Regulatory Filings
2016-11-21 English
OSLO BØRS - MATCHING HALT
Regulatory Filings
2016-11-21 English
KEY INFORMATION RELATING TO THE PROPOSED UNDERWRITTEN RIGHTS ISSUE IN PCI BIOTECH HOLDING ASA
Capital/Financing Update
2016-11-17 English
PCI Biotech: Notice to the extraordinary general meeting to resolve a fully underwritten Rights Issue of NOK 70 million
AGM Information
2016-11-17 Norwegian
PCI Biotech: Notice to the extraordinary general meeting to resolve a fully underwritten Rights Issue of NOK 70 million
Capital/Financing Update
2016-11-17 English
PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 70 million
Capital/Financing Update
2016-11-17 English
PCI Biotech: Distribution of today's presentation
Investor Presentation
2016-11-10 English
PCI Biotech: Distribution of today's presentation
Report Publication Announcement
2016-11-10 English
PCI Biotech to present at BIO-Europe 2016
Regulatory Filings
2016-11-08 English
PCI Biotech: Invitation to in-depth company update
Regulatory Filings
2016-11-02 English
PCI Biotech: Update on funding of further development
Share Issue/Capital Change
2016-10-27 English
PCI Biotech: Distribution of todays presentation at United European Gastroenterology Week
Investor Presentation
2016-10-17 English
PCI Biotech: Distribution of todays presentation at United European Gastroenterology Week
Investor Presentation
2016-10-17 English
PCI Biotech: Results from the bile duct cancer study will be presented as late-breaking news at United European Gastroenterology Week
Regulatory Filings
2016-10-17 English
PCI Biotech to present phase I results at Nordic Life Science Days 2016
Investor Presentation
2016-09-13 English
PCI Biotech to present phase I results at Nordic Life Science Days 2016
Report Publication Announcement
2016-09-13 English
Flaggemelding PCI Biotech Holding ASA
Major Shareholding Notification
2016-09-08 Norwegian
PCI Biotech: Independent evaluation confirms early promising signs of efficacy in the phase I/II bile duct cancer study
Regulatory Filings
2016-09-06 English
PCI Biotech: First subject dosed in the fimaVACC phase I study
Regulatory Filings
2016-09-05 English
PCI Biotech and BioNTech initiates preclinical research collaboration
Regulatory Filings
2016-09-01 English
PCI Biotech: Second quarter and first half year 2016 results
Investor Presentation
2016-08-30 English
PCI Biotech: Second quarter and first half year 2016 results
Interim / Quarterly Report H1 2016
2016-08-30 English
PCI Biotech: Second quarter and first half year 2016 results
Earnings Release H1 2016
2016-08-30 English
PCI Biotech granted Orphan Drug Designation of fimaporfin for treatment of cholangiocarcinoma in EU
Legal Proceedings Report
2016-08-29 English
PCI Biotech: Invitation to second quarter and first half year 2016 presentation
Report Publication Announcement
2016-08-24 English
PCI Biotech: Publication of the fimaporfin (Amphinex) first-in-man Phase I study in Lancet Oncology
Regulatory Filings
2016-07-28 English
PCI Biotech receives positive opinion for Orphan Drug Designation of fimaporfin for treatment of cholangiocarcinoma in EU
Environmental & Social Information
2016-07-25 English
PCI Biotech: Pre-clinical research collaboration agreement with top-10 large pharma company extended
Regulatory Filings
2016-05-26 English
PCI Biotech: Minutes from Annual General Meeting 2016
AGM Information
2016-05-19 English
PCI Biotech: Minutes from Annual General Meeting 2016
AGM Information
2016-05-19 English
PCI Biotech: Mandatory notification of trade
Director's Dealing
2016-05-04 English
PCI Biotech: First quarter 2016 report
Interim / Quarterly Report Q1 2016
2016-05-03 English
PCI Biotech: First quarter 2016 report
Report Publication Announcement Q1 2016
2016-05-03 English
PCI Biotech: Notice of Annual General Meeting 2016
AGM Information
2016-04-26 English
PCI Biotech: Notice of Annual General Meeting 2016
Board/Management Information
2016-04-26 English
PCI Biotech: Notice of Annual General Meeting 2016
Remuneration Information
2016-04-26 English
PCI Biotech: Notice of Annual General Meeting 2016
AGM Information
2016-04-26 English
PCI Biotech: Annual Report 2015
Annual Report FY 2015
2016-04-11 English
PCI Biotech: Annual Report 2015
Report Publication Announcement
2016-04-11 English
PCI Biotech: Fourth quarter and preliminary full year 2015 results
Earnings Release Q4 2015
2016-02-09 English
PCI Biotech: Fourth quarter and preliminary full year 2015 results
Investor Presentation
2016-02-09 English
PCI Biotech: Fourth quarter and preliminary full year 2015 results
Report Publication Announcement
2016-02-09 English
PCI Biotech: Invitation to fourth quarter and preliminary full year 2015 presentation
Report Publication Announcement
2016-02-02 English
PCI Biotech and Ultimovacs initiates preclinical research collaboration
M&A Activity
2016-01-27 English
PCI Biotech: Dose escalation in the bile duct cancer study completed with promising early signs of efficacy
Earnings Release Q1 2016
2016-01-22 English